Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 254.91M | 259.86M | 250.36M | 184.44M | 125.81M |
Gross Profit | 69.81M | 78.39M | 89.19M | 66.70M | 41.48M |
EBITDA | 35.37M | 45.02M | 54.10M | 42.56M | 23.20M |
Net Income | 791.00K | 10.81M | 25.73M | 18.43M | 17.15M |
Balance Sheet | |||||
Total Assets | 553.59M | 571.87M | 550.59M | 475.84M | 382.71M |
Cash, Cash Equivalents and Short-Term Investments | 44.09M | 54.60M | 90.52M | 148.71M | 214.54M |
Total Debt | 154.37M | 145.10M | 118.19M | 57.85M | 40.62M |
Total Liabilities | 219.32M | 226.72M | 214.75M | 152.76M | 93.84M |
Stockholders Equity | 333.00M | 342.50M | 333.08M | 319.84M | 287.87M |
Cash Flow | |||||
Free Cash Flow | 14.75M | 18.59M | 14.78M | -5.83M | 17.08M |
Operating Cash Flow | 40.64M | 39.74M | 62.44M | 44.55M | 31.65M |
Investing Cash Flow | -41.48M | -87.63M | -147.91M | -107.44M | -25.89M |
Financing Cash Flow | -10.22M | 12.91M | 30.66M | -5.54M | -2.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
57 Neutral | HK$3.03B | 496.67 | 0.23% | ― | -2.22% | -92.77% | |
52 Neutral | $7.36B | -0.07 | -63.77% | 2.81% | 16.35% | 0.03% | |
― | $4.64B | 0.93 | -6.09% | ― | ― | ― | |
59 Neutral | HK$39.34B | ― | -19.78% | ― | 25.96% | 39.58% | |
― | HK$29.40B | 37.56 | 10.27% | 2.95% | ― | ― | |
72 Outperform | HK$34.24B | 38.49 | 31.65% | ― | 4.23% | 47.71% | |
― | HK$9.34B | 105.24 | 4.95% | ― | ― | ― |
Frontage Holdings Corporation announced a change in its executive team with the resignation of Mr. Jun (Henry) Gao as Chief Financial Officer, effective July 15, 2025, due to his pursuit of other professional endeavors. Ms. Huan Wang, with extensive experience in the pharmaceutical and CRO industry, will assume the role of interim CFO. This transition is expected to maintain the company’s financial stability and strategic direction, given Ms. Wang’s long-standing involvement with the company and her role in its financial operations.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
Frontage Holdings Corporation, a company incorporated in the Cayman Islands, has announced changes in its Nomination Committee effective June 30, 2025. The changes, which comply with upcoming amendments to the Hong Kong Stock Exchange’s Listing Rules and Corporate Governance Code, include the appointment of Ms. Zhuan Yin and Mr. Yifan Li as members. The Board believes these changes will enhance the committee’s effectiveness and diversity, strengthening the company’s corporate governance practices.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
Frontage Holdings Corporation, a company incorporated in the Cayman Islands, has announced changes to its board of directors and committee memberships effective June 30, 2025. The announcement details the roles and functions of its executive, non-executive, and independent non-executive directors, highlighting the leadership positions within the Audit and Risk Management, Remuneration, and Nomination Committees. This restructuring is likely to impact the company’s governance and strategic direction, potentially influencing its market positioning and stakeholder relationships.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
Frontage Holdings Corporation has updated the terms of reference for its Nomination Committee, which was originally established in 2018. The committee will consist of at least three non-executive directors, with a majority being independent and at least one member of a different gender, reflecting the company’s commitment to diversity and governance.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
Frontage Holdings Corporation has announced the composition of its Board of Directors and the roles within its various committees. This update includes the appointment of executive, non-executive, and independent non-executive directors, which is crucial for stakeholders as it reflects the company’s governance structure and strategic oversight.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
Frontage Holdings Corporation, a company incorporated in the Cayman Islands, announced the results of its Annual General Meeting (AGM) held on May 28, 2025. All proposed resolutions were passed, including the appointment of new executive directors Dr. Wentao Zhang and Dr. Zhongping Lin, and the re-election of non-executive directors. The meeting also approved the reappointment of BDO Limited as the company’s auditor and authorized the board to manage director remuneration and share repurchase mandates.
The most recent analyst rating on (HK:1521) stock is a Hold with a HK$1.57 price target. To see the full list of analyst forecasts on Frontage Holdings Corp. stock, see the HK:1521 Stock Forecast page.
Frontage Holdings Corporation announced its unaudited financial results for the first quarter of 2025, reporting a net loss of approximately US$0.9 million, slightly improved from a US$1.0 million loss in the same period of 2024. The company’s revenue decreased by 10.6% to US$57.1 million compared to the previous year. Despite these challenges, the adjusted net profit was US$1.6 million after excluding certain expenses, indicating ongoing financial adjustments. The announcement highlights the importance of cautious trading by shareholders and potential investors due to the unaudited nature of the financial data.
Frontage Holdings Corporation has announced its upcoming annual general meeting, scheduled for May 28, 2025, in Shanghai, China. Key agenda items include the adoption of the company’s audited financial statements for 2024, the appointment and re-election of directors, and the reappointment of BDO Limited as the company’s auditor. Additionally, the meeting will address resolutions concerning the repurchase of shares and the issuance of additional shares, reflecting the company’s strategic focus on maintaining financial flexibility and shareholder value.